Evaluation of mangafodipir treatment for oxaliplatin-associated neuropathy

An unfortunate side effect of the platinum-chemotherapy drug oxaliplatin is the development of neurotoxicity, which can adversely affect a patient's quality of life; therefore, the benefit of oxaliplatin-based therapy must be balanced with prevention of neuropathies. Currently, there are no therapeutic interventions available to relieve oxaliplatin-associated neurological symptoms, which are thought to be a result … Continue reading Evaluation of mangafodipir treatment for oxaliplatin-associated neuropathy

Advertisements

Saving fertility not priority at most cancer centers

Lack of policies to protect cancer patient's fertility at top cancer centers Infertility is consistently listed as one of the most distressing long-term side effects of cancer treatment for adolescents and young adults. Yet the leading National Cancer Institute-designated comprehensive cancer centers -- which should be leaders in fertility preservation -- aren't doing an adequate … Continue reading Saving fertility not priority at most cancer centers

Researchers find potential new treatment approach for pancreatic cancer

Scientists from The University of Manchester – part of Manchester Cancer Research Centre believe they have discovered a new way to make chemotherapy treatment more effective for pancreatic cancer patients. Pancreatic cancer is an aggressive cancer with poor prognosis and limited treatment options and is highly resistant to chemotherapy and radiotherapy. But researchers believe they have … Continue reading Researchers find potential new treatment approach for pancreatic cancer

Fatigue, a common side effect of breast cancer treatment, evaluated in novel patient study

Clinical trial aims to identify why some breast cancer patients are at high risk for post-treatment fatigue Although the prevalence and impact of cancer-related fatigue has been well established, very little is known about its predictors, mechanisms for development, and persistence post-treatment. A new research study at the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute, in … Continue reading Fatigue, a common side effect of breast cancer treatment, evaluated in novel patient study

Advances in nanotechnology’s fight against cancer

As cancer maintains its standing as the second leading cause of death in the U.S., researchers have continued their quest for safer and more effective treatments. Among the most promising advances has been the rise of nanomedicine, the application of tiny materials and devices whose sizes are measured in the billionths of a meter to … Continue reading Advances in nanotechnology’s fight against cancer

Breaking down cancer’s defense mechanisms

A possible new method for treating pancreatic cancer which enables the body's immune system to attack and kill cancer cells has been developed by researchers. The method uses a drug which breaks down the protective barrier surrounding pancreatic cancer tumours, enabling cancer-attacking T cells to get through. The drug is used in combination with an … Continue reading Breaking down cancer’s defense mechanisms

Keep on exercising, researchers advise older breast cancer survivors

One year of exercise can ensure steady maintenance of bone density to help prevent fractures To build and maintain muscle strength, it is best for older breast cancer survivors to follow an ongoing exercise program of resistance and impact training. This advice comes from Jessica Dobek of the Oregon Health and Science University, lead author … Continue reading Keep on exercising, researchers advise older breast cancer survivors

Breakthrough in treating leukemia, lymphoma with umbilical cord blood stem cells

Study finds that growing stem cells in lab before transplant boosts survival Donated umbilical cord blood contains stem cells that can save the lives of patients with leukemia, lymphoma and other blood cancers. Now a study lead by a Loyola University Medical Center oncologist has found that growing cord blood stem cells in a laboratory before … Continue reading Breakthrough in treating leukemia, lymphoma with umbilical cord blood stem cells

Targeted treatment can significantly reduce relapse in children with AML leukemia

Findings from nationwide study led by Children's Mercy researcher highlighted at American Society of Hematology Meeting The addition of a monoclonal antibody called gemtuzumab combined with standard chemotherapy has been shown to significantly reduce the risk of relapse and increase rates of disease-free survival in pediatric patients with acute myeloid leukemia (AML). Post-treatment relapse rates … Continue reading Targeted treatment can significantly reduce relapse in children with AML leukemia